Showing results (181-190 of 253) with videos related to
Sort By:
Pageof 26
The Journal of Clinical Endocrinology and Metabolism|April 24, 2012
Benefits and risks of bisphosphonate therapy for osteoporosisSundeep Khosla, John P Bilezikian, David W Dempster, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 18, 2025
Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone DiseasesE Michael Lewiecki, John P Bilezikian, Amanda Clark, et al.The American Journal of Medicine|November 27, 2012
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holidayMichael McClung, Steven T Harris, Paul D Miller, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 6, 2019
Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone DiseasesE Michael Lewiecki, John P Bilezikian, Risa Kagan, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 17, 2021
Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone DiseasesE Michael Lewiecki, Paul A Anderson, John P Bilezikian, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 7, 2023
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized StudyE Michael Lewiecki, Edward Czerwinski, Chris Recknor, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|March 30, 2016
Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry GuidanceE Michael Lewiecki, Neil Binkley, Sarah L Morgan, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 10, 2017
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM ExtensionNelson B Watts, Jacques P Brown, Socrates Papapoulos, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 12, 2013
Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosisE Michael Lewiecki, Paul D Miller, Steve T Harris, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 9, 2023
Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal DiseasesE Michael Lewiecki, Teresita Bellido, John P Bilezikian, et al.Pageof 26